CABA
CABALETTA BIO (CABA)
NASDAQ
$3.58$0.00 (0.00%)
Price as of Jun 03, 2026 7:59 PM EDT
  • $616.3M
    Market Cap
  • 61.99%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-142.7M
+4,655.80%
-3.0M
-94.59%
-55.4M
+41.03%
-39.3M
+20.95%
Depreciation and Amortization Expense
1.6M
-3.80%
1.7M
+19.99%
1.4M
+21.05%
1.2M
+60.71%
Total Operating Expenses
172.2M
+37.64%
125.1M
+67.61%
74.7M
+37.90%
54.1M
+16.90%
Operating Profit
-172.2M
+37.64%
-125.1M
+67.61%
-74.7M
+37.90%
-54.1M
+16.90%
Interest Income
6.0M
-39.84%
10.0M
+43.52%
7.0M
+500.09%
1.2M
+4,750.00%
Interest Expense
-2.0M
+167.91%
-748,000
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
4.0M
-56.59%
9.3M
+32.81%
7.0M
+500.09%
1.2M
+4,750.00%
Total Nonoperating Income and Expense
2.0M
+167.91%
748,000
N/A
N/A
N/A
N/A
N/A
Income before Taxes
-172.2M
+37.64%
-125.1M
+67.61%
-74.7M
+37.90%
-54.1M
+16.90%
Income Taxes
0
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-167.9M
+44.87%
-115.9M
+71.21%
-67.7M
+27.75%
-53.0M
+14.44%
Net Income from Continuing Operations Applicable to Common
-167.9M
+44.87%
-115.9M
+71.21%
-67.7M
+27.75%
-53.0M
+14.44%
Basic EPS and Net Income
-2.10
-10.26%
-2.34
+41.82%
-1.65
-8.84%
-1.81
+0.56%
Diluted EPS and Net Income
-2.10
-10.26%
-2.34
+41.82%
-1.65
-8.84%
-1.81
+0.56%
Basic Weighted Average Shares
6.0M
-87.76%
49.0M
+4,098.33%
1.2M
-80.34%
5.9M
-72.18%
Diluted Weighted Average Shares
49.5M
0.00%
49.5M
+20.95%
40.9M
+39.54%
29.3M
+14.01%
Balance Sheet
Cash and Cash Equivalents
83.0M
-49.39%
164.0M
-15.15%
193.2M
+136.79%
81.6M
-33.23%
Short-Term Investments
50.6M
N/A
0
-100.00%
48.0M
+92.51%
24.9M
+244.81%
Cash and Cash Equivalents and Short-Term Investments
133.6M
-18.52%
164.0M
-32.04%
241.2M
+126.42%
106.5M
-17.70%
Total Current Assets
138.9M
-16.68%
166.7M
-31.83%
244.5M
+124.64%
108.8M
-12.61%
Accumulated Depreciation
7.2M
+29.89%
5.5M
+45.09%
3.8M
+60.19%
2.4M
+98.91%
Property and Plant and Equipment and Net
1.9M
-29.93%
2.7M
+7.95%
2.5M
-1.44%
2.6M
+79.28%
Total Long-Term Assets
5.2M
+124.99%
2.3M
+34.17%
1.7M
+202.48%
565,000
+58.26%
Total Assets
165.1M
-10.79%
185.0M
-27.05%
253.7M
+116.85%
117.0M
-7.42%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
50.2M
+85.16%
27.1M
+69.35%
16.0M
+68.55%
9.5M
+13.23%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
0
-100.00%
2.4M
+63.51%
1.5M
-50.73%
3.0M
N/A
Total Liabilities
53.0M
+62.12%
32.7M
+87.43%
17.5M
+40.20%
12.4M
+48.54%
Retained Earnings
-517.0M
+48.08%
-349.1M
+49.68%
-233.2M
+40.88%
-165.6M
+47.05%
Total Stockholders Equity
112.1M
-26.44%
152.3M
-35.51%
236.2M
+125.98%
104.5M
-11.39%
Total Shares Outstanding
100.5M
+98.02%
50.7M
+6.11%
47.8M
+62.41%
29.4M
+1.79%
Cash Flow
Cash from Operating Activities
-131.1M
+48.58%
-88.2M
+64.75%
-53.5M
+15.46%
-46.4M
+35.98%
Capital Expenditures
1.2M
-44.41%
2.2M
+221.83%
687,000
-71.99%
2.5M
+110.38%
Cash from Investing Activities
-50.3M
-206.30%
47.3M
+310.63%
-22.5M
-17.51%
-27.2M
-553.69%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
100.3M
+759.36%
11.7M
-93.78%
187.6M
+468.89%
33.0M
-32.56%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-95.88%
+81.52%
-52.82%
+44.64%
-36.52%
-16.14%
-43.55%
+13.39%
Return on Equity
-126.98%
+112.90%
-59.64%
+50.14%
-39.72%
-16.58%
-47.62%
+17.03%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
2.77
-55.00%
6.15
-59.75%
15.29
+33.28%
11.47
-22.83%
Cash Ratio
1.65
-72.67%
6.05
-49.90%
12.08
+40.48%
8.60
-41.03%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow